Sign inJoin waitlistJoin the waitlist

SS

Sandra Springer

Associate Program Director · Yale-New Haven Hospital

Credentials: · ·

History

Yale-New Haven Hospital
Present
Yale-New Haven Hospital
Present

Infectious Disease
Yale School of Medicine
1998–2000
University of Massachusetts Medical School
1994–1998
Harvard University
1987–1990
Harvard University

Research

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel
JAMA · 2023 · 462 citations
A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization
Systematic review or meta-analysis · Drug and Alcohol Dependence · 2010 · 332 citations
Substance abuse, violence, and HIV in women: a literature review of the syndemic
Review · Journal of Women s Health · 2011 · 260 citations

Frederick Altice
54 papers
IK
Irene Kuo
16 papers
Carlos del Rio
12 papers
Jaimie Meyer
10 papers · 8 as a fellow
Curt Beckwith
8 papers
Heidi Crane
8 papers
MA
Marwan Azar
8 papers
Ank Nijhawan
7 papers
AS
Anne Spaulding
7 papers
Edward Nunes
7 papers
Nikhil Seval
6 papers · 2 as a fellow
RB
Robert Bruce
6 papers

Grants

GEO IMPACT: Geo-Targeted Implementation of a Novel Mobile Pharmacy and Clinic Healthcare Delivery Model with Community HeAlth Workers for Prevention, Care and Treatment of HIV and Substance Use
National Institute on Drug Abuse · RM1
Contact PI · $2.2M · Yale University
2026–2031
“GLP-1 Outcomes with People Using Psychoactive Substances (GLOW-UPS): A Multi-Stage, Multi-Site Trial Among Persons Involved in the Criminal-Legal System
National Institute on Drug Abuse · UM1
PI · $2.8M · New York University School of Medicine
2025–2030
Effects of Medication for Opioid Use Disorder on Microglial Activation and Neurocognition in People Living with HIV
National Institute on Drug Abuse · R01
PI · $3.5M · Yale University
2024–2029
STOP (Shared Decision Making to Treat Or Prevent) HIV in Criminal Legal Involved Populations
National Institute on Drug Abuse · R33
Contact PI · $2.9M · Yale University
2024–2029

Clinical trials

Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic
Principal investigator · Not yet recruiting · Phase 4
Yale University
2026–2027
RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry
Principal investigator · Recruiting
University of Texas Southwestern Medical Center
2026–2027
Shared Decision Making to Treat Or Prevent (STOP) HIV in Criminal Legal Involved Populations (R33)
Principal investigator · Recruiting
Yale University
2025–2028
STOP (Shared Decision Making to Treat Or Prevent) HIV in Justice Populations
Principal investigator · Completed
Yale University
2024–2025